Biopharma Plastics Market to Grow with a CAGR of 5.23% through 2030
Rising demand from the Healthcare sector is expected to
drive the Biopharma Plastics market in the forecast period 2026-2030F.
According to TechSci Research report, “Biopharma Plastics Market -
Global Industry Size, Share, Trends, Opportunity, and Forecast,
2020-2030F”, Global Biopharma Plastics Market was valued at USD
5.47 Billion in 2024 and is expected to reach USD 7.34 Billion by 2030 with a
CAGR of 5.23%. The biopharma plastic market is witnessing significant
technological innovations driven by the need for higher performance, safety,
and compliance with stringent regulatory standards in pharmaceutical
manufacturing and bioprocessing. One of the major advancements is the
development of high-performance engineering plastics such as
polyetheretherketone (PEEK), cyclic olefin copolymers (COC), and advanced
polypropylene blends, which offer exceptional chemical resistance,
transparency, and mechanical strength. These materials enhance product
stability and compatibility with sensitive biologics. Single-use systems
(SUS) represent a major technological leap in the biopharma sector. Innovations
in biopharma-grade plastic films and bags, connectors, and tubing have enabled
disposable bioprocessing equipment that reduces contamination risks, simplifies
cleaning validation, and improves process efficiency. Modern single-use
plastics are being engineered to withstand high gamma radiation doses for
sterilization while maintaining mechanical integrity.
Advanced polymer formulation technologies are enabling
plastics with enhanced temperature endurance and resistance to aggressive
cleaning agents. This has expanded the usability of plastics in
high-temperature processes like steam sterilization and high-pressure liquid
chromatography (HPLC) applications. Nanotechnology integration is another
key advancement, enabling the creation of nanocomposite plastics with superior
barrier properties, improved mechanical strength, and antimicrobial
characteristics crucial for aseptic pharmaceutical production. Additionally,
smart and functionalized plastics embedded with sensors are emerging, allowing
real-time monitoring of parameters such as pH, pressure, and temperature during
bioprocessing. For instance, in 2021, the acquisition of Johnson
Plastic Group (JPG), a maker of precision extrusions, by Tekni-Plex Healthcare
is a part of a plan to broaden the company's patient care solutions platform.
Sustainability is also shaping technological progress. The
introduction of bio-based and recyclable plastics derived from renewable
feedstocks is addressing environmental concerns without compromising
performance. These materials comply with USP Class VI and ISO 10993 standards,
ensuring biocompatibility for pharmaceutical use. Technological
advancements in the biopharma plastic market are enhancing performance,
sterility assurance, and sustainability while enabling flexible, efficient, and
contamination-free pharmaceutical manufacturing processes.
Browse over XX market data Figures spread through XX
Pages and an in-depth TOC on the "Global Biopharma Plastics Market"
Global Biopharma Plastics Market is segmented based on polymer type,
application, and region.
Based on application, The syringes segment is anticipated to hold the
largest market share during the forecast period. This dominance is primarily
attributed to their ease of use, cost-effectiveness, and ability to minimize
microbial contamination. Syringes offer greater accuracy in dosage delivery,
reducing the risk of injection and dilution errors. Their widespread use in
hospitals, clinics, and home care settings for vaccine administration, drug
delivery, and fluid extraction further boosts demand. The availability of
disposable syringes also ensures enhanced safety and hygiene, supporting
infection control practices. Continuous improvements in syringe design and
manufacturing are expected to further drive growth in this segment over the
forecast period.
Based on region, the Asia pacific region is
expected to grow at fastest rate in the forecast
period,2020-2030F. This growth is driven by the increasing adoption of
biopharma plastics in medical and pharmaceutical applications, owing to their
unique properties such as extreme flexibility, high resistance to chemicals,
and excellent endurance under elevated temperatures. The region’s expanding
healthcare infrastructure, rising pharmaceutical production, and strong
investments in biotechnology research are further fueling demand. Additionally,
the growing shift toward advanced materials for drug manufacturing and delivery
systems, coupled with supportive government policies and increasing healthcare
expenditure, is expected to solidify Asia-Pacific’s position as a key growth
hub in the global biopharma plastics market.
Major companies operating in the global Biopharma
Plastics market are:
- BASF
SE
- Spectrum
Plastics Group
- Celanese
Corporation
- LyondellBasell
Industries Holdings B.V.
- DuPont
de Nemours, Inc.
- Tekni-Plex,
Inc.
- Solvay
S.A.
- Avantor,
Inc.
- Bormioli
Pharma S.p.A.
- Saudi
Basic Industries Corporation
Download Free Sample ReportCustomers can also request for 10% free customization on this report.
“The global biopharma plastic market is witnessing significant growth, driven
by increasing demand for lightweight, durable, and chemically resistant
materials in biopharmaceutical applications. These plastics are essential for
manufacturing bioprocessing equipment, medical devices, and packaging, offering
advantages such as high purity, sterilizability, and cost-effectiveness.
Technological advancements, including the development of high-performance
polymers with improved biocompatibility and barrier properties, are expanding
their applications in drug manufacturing and storage. Rising adoption of
single-use systems in biopharma production and growing emphasis on
contamination prevention are further fueling market expansion. Increasing
investments in biotechnology, coupled with regulatory support for safe and
sustainable materials, are expected to sustain strong market growth in the
coming years,” said Mr. Karan Chechi, Research Director of TechSci
Research, a research-based global management consulting firm.
“Biopharma Plastics Market - Global Industry Size, Share,
Trends, Opportunity, and Forecast, Segmented By Polymer Type (Polyvinyl
Chloride (PVC), Polyethylene Terephthalate (PET), Polypropylene (PP), Others),
By Application (Protective Wear, Containers, Bioreactor Bags, Syringes,
Others), By Region and Competition, 2020-2030F", has evaluated the future
growth potential of Global Biopharma Plastics Market and provides statistics
& information on market size, structure, and future market growth. The
report intends to provide cutting-edge market intelligence and help decision-makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in the Global Biopharma Plastics Market.”
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com